Back to Search
THOMAS STROUP, MD
MD
Psychiatry Physician
NPI: 1497843171Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
252758(NY)
Research & Publications (20)
A candidate gene study of Tardive dyskinesia in the CATIE schizophrenia trial.
PMID 19475583·Am J Med Genet B Neuropsychiatr Genet·2010
4-observational
Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.
PMID 19640511·Biol Psychiatry·2009
3-trial
Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study.
PMID 19369318·Am J Psychiatry·2009
4-observational
Genomewide association for schizophrenia in the CATIE study: results of stage 1.
PMID 18347602·Mol Psychiatry·2008
2-rct
Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia.
PMID 18700216·Br J Psychiatry·2008
4-observational
Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study.
PMID 18775645·Schizophr Res·2008
4-observational
Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia.
PMID 17588543·Biol Psychiatry·2008
3-trial
Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1.
PMID 18534821·Schizophr Res·2008
3-trial
The neuregulin 1 promoter polymorphism rs6994992 is not associated with chronic schizophrenia or neurocognition.
PMID 18286587·Am J Med Genet B Neuropsychiatr Genet·2008
8-other
Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1.
PMID 18258416·Schizophr Res·2008
3-trial
Employment outcomes in a randomized trial of second-generation antipsychotics and perphenazine in the treatment of individuals with schizophrenia.
PMID 18246429·J Behav Health Serv Res·2008
2-rct
The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study.
PMID 18191383·Schizophr Res·2008
4-observational
Randomized controlled trials for schizophrenia: study designs targeted to distinct goals.
PMID 18245060·Schizophr Bull·2008
6-review
Extrapyramidal side-effects of antipsychotics in a randomised trial.
PMID 18827289·Br J Psychiatry·2008
4-observational
Determining when impairment constitutes incapacity for informed consent in schizophrenia research.
PMID 17602123·Br J Psychiatry·2007
4-observational
Risperidone versus olanzapine for treatment of schizophrenia.
PMID 17921477·Schizophr Bull·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1051 RIVERSIDE DR
NEW YORK, NY 10032 - Phone
- (646) 774-8435
Quick Facts
- NPI
- 1497843171
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile